This month’s GROWTH Commentary is the final contribution to the 5-part series of commentaries reflecting on the past 4 years since the landmark Institute of Medicine (IOM, now the National Academy of Medicine) reports on Clinical Practice Guidelines We Can Trust and Finding What Works in Health Care: Standards for Systematic Reviews were published. 

In previous essays,

• Sheldon Greenfield, MD, as Chair of the first of these reports, launched this series by commenting on the state of guidelines and guideline development today. 
• Mary Nix, MS, PMP, Staff Lead of the AHRQ National Guidelines Clearinghouse (NGC), discussed the NGC inclusion criteria that were revamped as a result of recommendations from the IOM report and how the revised criteria have impacted the submissions of guidelines. 
• Tom Oliver, Guidelines Director at the American Society of Clinical Oncology, contemplated the two IOM reports and how they have impacted the work of guideline developers, specifically ASCO.
• Peg Ford, a leading consumer representative, addressed how the IOM reports affected patient engagement.
• Sally Morton, PhD, Vice Chair of the IOM report, concludes this series by reviewing how this report influenced the field of systematic reviews and guideline development: Reflecting on the Past 4 Years Since the IOM Established Standards for Systematic Reviews and Guidelines.

The GROWTH Commentary is designed to be interactive.

 For more information about the conference and to register,
visit the conference website at http://www.gin2015.net/